Direct Admission Versus Interhospital Transfer for Primary Percutaneous Coronary Intervention in ST-Segment Elevation

Damian Kawecki1, Marek Gierlotka2, Beata Morawiec1

  • 12nd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland.

Insights

Direct admission for ST-segment elevation myocardial infarction (STEMI) patients to a percutaneous coronary intervention (PCI) center reduces time delays and 12-month mortality compared to interhospital transfer. This approach should be preferred for better patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Reducing reperfusion delays is critical for ST-segment elevation myocardial infarction (STEMI) patient care.
  • The comparative effectiveness of direct admission versus interhospital transfer to percutaneous coronary intervention (PCI) centers on long-term outcomes remains debated.
  • Direct admission is hypothesized to improve outcomes by shortening ischemic time and preserving left ventricular function.

Purpose of the Study:

  • To evaluate the impact of direct admission versus interhospital transfer to a PCI center on time delays and 12-month mortality in STEMI patients.
  • To assess the real-world effectiveness of different STEMI patient pathways on clinical outcomes.
  • To determine if direct admission is superior to interhospital transfer for STEMI patients undergoing PCI.

Main Methods:

  • Analysis of prospective nationwide registry data of STEMI patients treated with PCI between 2006 and 2013.
  • Comparison of patients directly admitted to PCI centers versus those transferred from regional non-PCI-capable facilities.
  • Adjustment for confounding factors using propensity-matched and multivariate Cox analyses to assess time delays, left ventricular ejection fraction (LVEF), and 12-month mortality.

Main Results:

  • Direct admission (56% of 70,093 patients) was associated with significantly shorter symptom-to-admission time (44 min reduction) and total ischemic time (228 vs. 270 min).
  • Patients directly admitted had higher left ventricular ejection fraction (LVEF) and lower propensity-matched 12-month mortality (9.6% vs. 10.4%).
  • Direct admission and shorter symptom-to-admission times were independent predictors of reduced 12-month mortality in multivariate analysis.

Conclusions:

  • Direct admission to a primary PCI center is associated with improved outcomes, including lower 12-month mortality, in STEMI patients treated with PCI.
  • Transfer via a regional non-PCI-capable facility should be avoided in favor of direct admission when possible for STEMI patients.
  • Optimizing STEMI care pathways through direct admission can significantly improve survival rates.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
360
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
594
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357